Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP

Executive Director, Biosafety Services, Advarra

Latest Posts by Daniel Eisenman

Blog

How Integrated IRB and IBC Administration Facilitate a New Era of Interventional Genetic Therapeutics 

Gene therapies and gene-based therapeutics are giving way to a new era of interventional genetics. Integrated ethics review and...

Read More...
Photo of real female scientists researching in laboratory.
Blog

The Heart’s Broken Blueprint: Rewriting the Cardiovascular Playbook with Gene Therapy 

Cardiovascular disease remains a worldwide challenge, causing undue strain on the health system and contributing substantial patient burden. For decades,...

Read More...
Blog

Gene Therapy Is Seen as the Next Big Biologic in Ophthalmology

Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular...

Read More...
Blog

The Executive Order that Brings Private Bioresearch Under Federal Oversight

The release of ICH E6(R3) in January 2025 marks the most significant evolution in Good...

Read More...
Blog

Bacteriophage Therapy: A Promising Solution to Antibiotic Resistance

Antibiotic resistance is an emerging problem. Some have argued bacteria are developing antibiotic resistance faster...

Read More...
Blog

How Genetic Engineering Will Move Rare Disease Research at Warp Speed

Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and...

Read More...
Blog

Operation Warp Speed for Rare Diseases: Expected Boom in Drug Development and Approval

Rapid growth in gene therapy is expected to receive additional support as the Food and...

Read More...
Blog

How Centralized IBC Review Can Benefit Gene Therapy Research

Gene therapy research is at the forefront of a coming boom in the clinical setting....

Read More...
Blog

Reporting Unexpected Incidents to the IBC

When unexpected events occur during the conduct of a clinical trial, research personnel may wonder...

Read More...
Blog

IBC vs. IRB: What’s the Difference?

Gene therapy research requires both IRB and IBC oversight—while IRBs protect participants, IBCs ensure community...

Read More...
Blog

Safe Sharps Handling When Dispensing Investigational Products

Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe...

Read More...
Blog

Clean Bench vs Biosafety Cabinet: What’s the Difference?

Institutional biosafety committees (IBCs) frequently receive questions about the proper type of hood for use...

Read More...
Login
Scroll to Top